Background: The COVID 19 pandemic has greatly disrupted high performance sport and international competition. The aim of this study was to quantify the impact of the COVID-19 pandemic on the world's top 10 performances in Athletics and Swimming among non-disabled and Paralympic athletes.
Methods: The results of the 10-best world performers in 66 Olympic events since 1891 and 255 Paralympic events since 2010 were collected. To quantify the performance trend, the slopes of the 4 years moving average were calculated and analyzed by time period. The distribution of performances (in % of the world record) by year was analyzed to compare the 2020 values to the ten previous years. The stability rate (athletes joining and leaving each year) since 2010 and the number of annual competitions events were also measured.
Results: Over the study period, such declines in performance have only been observed during the two World Wars. In 2020, the level of performances has decreased significantly, corresponding to a 6 to 10 years setback. In 2020, the number of new athletes in the 10-best was significantly higher with a lower number of organized competitions.
Conclusions: The impact on the performances of the best international non-disabled and Para athletes has been considerable.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.23736/S0022-4707.22.13365-7 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Immunogenicity of bivalent versus monovalent mRNA booster vaccination among adult paramedics in Canada who had received three prior mRNA wild-type doses.
Access Microbiol
January 2025
Department of Emergency Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Comparative immunogenicity from different mRNA booster vaccines (directed at WT, BA.1 or BA.4/5 antigens) remains unclear.
View Article and Find Full Text PDFOcular Symptoms Among COVID-19 Positive Patients in Saudi Arabia: A Cross-Sectional Survey.
Cureus
December 2024
College of Medicine, Qassim University, Buraydah, SAU.
Background Coronavirus disease (COVID-19), a widespread viral illness, has been linked to a range of respiratory and other systemic symptoms. Along with the respiratory symptoms caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), many extrapulmonary manifestations have also been reported. This study was conducted to report the ocular manifestations of COVID-19 in confirmed cases from the Qassim region, of Saudi Arabia.
View Article and Find Full Text PDFMedicinal plants for the management of post-COVID-19 fatigue: A literature review on the role and mechanisms.
J Tradit Complement Med
January 2025
School of Chinese Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, PR China.
Background: COVID-19 infection has a lasting impact on human health, which is known as post-COVID-19 conditions. Fatigue is one of the most commonly reported post-COVID-19 conditions. Management of fatigue in the post-COVID-19 era is necessary and emerging.
View Article and Find Full Text PDFNRICM101 in combatting COVID-19 induced brain fog: Neuroprotective effects and neurovascular integrity preservation in hACE2 mice.
J Tradit Complement Med
January 2025
National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei City, 112026, Taiwan.
Amidst growing concerns over COVID-19 aftereffects like fatigue and cognitive issues, NRICM101, a traditional Chinese medicine, has shown promise. Used by over 2 million people globally, it notably reduces hospitalizations and intubations in COVID-19 patients. To explore whether NRICM101 could combat COVID-19 brain fog, we tested NRICM101 on hACE2 transgenic mice administered the S1 protein of SARS-CoV-2, aiming to mitigate S1-induced cognitive issues by measuring animal behaviors, immunohistochemistry (IHC) staining, and next-generation sequencing (NGS) analysis.
View Article and Find Full Text PDFDisparities in response to mRNA SARS-CoV-2 vaccines according to sex and age: A systematic review.
New Microbes New Infect
February 2025
Department of Global and Public Health, Epidemiology, Biostatistics and Prevention Institute, WHO Collaborating Centre for Travellers' Health, Centre of Competence for Military Medicine Biology, University of Zürich, Switzerland.
Background: The rapid development and distribution of mRNA COVID-19 vaccines has been essential in containing the SARS-CoV-2 epidemic around the globe. For ongoing and future immunization campaigns globally, there is a need to evaluate the impact of population demographics such as age and sex, on vaccine efficacy and safety.
Methods: This systematic review (PROSPERO ID CRD42023328245) conducted according to PRISMA guidelines evaluates the impact of age and sex on the safety and efficacy of the mRNA COVID-19 vaccinations administrated in 15 studies that were chosen according to strict criteria.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!